Amirreza Khalaji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Amirreza Khalaji has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Mehdi Jafarpour
Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
7 shared publications Alireza Khabbazi
Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
5 shared publicationsLeyla Ghadakchi
Connective Tissue Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran
5 shared publications- Nasrin Gholami
Hematology and Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran
4 shared publications - Saba Mehrtabar
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
4 shared publications Amir Vahedi
Department of Pathology Tabriz University of Medical Sciences Tabriz Iran
3 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 566
Artificial intelligence in trigeminal neuralgia: trigeminal nerve segmentation and neurovascular conflict detection: a systematic review and meta-analysis
Trigeminal neuralgia (TN) is a debilitating condition characterized by severe, episodic facial pain, often caused by neurovascular conflict (NVC) at the trigeminal nerve root. Early and accurate diagnosis of TN is crucial for effective management, with microvascular decompression (MVD) being a common surgical treatment. While MRI plays a key role in detecting NVC, its subjective nature limits diagnostic precision. Recent advances in artificial intelligence (AI) offer promising tools for enhancing diagnostic accuracy. This study evaluates the potential of deep learning (DL) and machine learning (ML) models in improving TN diagnosis through automated segmentation and NVC detection in MRI scans. A comprehensive search was conducted across PubMed, Scopus, Embase, Web of Science, and the Cochrane Library to identify studies utilizing AI models in TN diagnosis. Studies assessing sensitivity, specificity, accuracy, and AUC were included in the meta-analysis. A total of 5 studies met the inclusion criteria, encompassing 577 patients with confirmed TN. The primary focus was on evaluating the performance of AI models in segmenting the trigeminal nerve and identifying neurovascular conflicts. The reference standard or target criterion used to define correct model performance was also extracted and considered, including expert imaging-based annotation, clinical-radiological diagnosis, and intraoperative confirmation where available. The pooled sensitivity of AI models in detecting TN was 71% (95% CI: 65–76%), with a specificity of 92% (95% CI: 88–94%). The positive diagnostic likelihood ratio (DLR) was 8.5 (95% CI: 5.75–12.56), and the negative DLR was 0.32 (95% CI: 0.26–0.38). The diagnostic odds ratio (DOR) was 26.71 (95% CI: 16.38–43.56), and the area under the curve (AUC) reached 0.91 (95% CI: 0.88–0.93). These findings demonstrate the high diagnostic accuracy of AI models, particularly in identifying NVC and improving preoperative planning for TN patients. AI models, particularly DL-based approaches, show promising diagnostic performance in the segmentation of the trigeminal nerve and detection of NVC. The high specificity and diagnostic odds ratio suggest that AI can play a critical role in enhancing clinical decision-making and improving the accuracy of TN diagnosis, ultimately aiding in better treatment planning for patients.
- 14 September 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 566
Open AccessArtificial intelligence in trigeminal neuralgia: trigeminal nerve segmentation and neurovascular conflict detection: a systematic review and meta-analysis
Trigeminal neuralgia (TN) is a debilitating condition characterized by severe, episodic facial pain, often caused by neurovascular conflict (NVC) at the trigeminal nerve root. Early and accurate diagnosis of TN is crucial for effective management, with microvascular decompression (MVD) being a common surgical treatment. While MRI plays a key role in detecting NVC, its subjective nature limits diagnostic precision. Recent advances in artificial intelligence (AI) offer promising tools for enhancing diagnostic accuracy. This study evaluates the potential of deep learning (DL) and machine learning (ML) models in improving TN diagnosis through automated segmentation and NVC detection in MRI scans. A comprehensive search was conducted across PubMed, Scopus, Embase, Web of Science, and the Cochrane Library to identify studies utilizing AI models in TN diagnosis. Studies assessing sensitivity, specificity, accuracy, and AUC were included in the meta-analysis. A total of 5 studies met the inclusion criteria, encompassing 577 patients with confirmed TN. The primary focus was on evaluating the performance of AI models in segmenting the trigeminal nerve and identifying neurovascular conflicts. The reference standard or target criterion used to define correct model performance was also extracted and considered, including expert imaging-based annotation, clinical-radiological diagnosis, and intraoperative confirmation where available. The pooled sensitivity of AI models in detecting TN was 71% (95% CI: 65–76%), with a specificity of 92% (95% CI: 88–94%). The positive diagnostic likelihood ratio (DLR) was 8.5 (95% CI: 5.75–12.56), and the negative DLR was 0.32 (95% CI: 0.26–0.38). The diagnostic odds ratio (DOR) was 26.71 (95% CI: 16.38–43.56), and the area under the curve (AUC) reached 0.91 (95% CI: 0.88–0.93). These findings demonstrate the high diagnostic accuracy of AI models, particularly in identifying NVC and improving preoperative planning for TN patients. AI models, particularly DL-based approaches, show promising diagnostic performance in the segmentation of the trigeminal nerve and detection of NVC. The high specificity and diagnostic odds ratio suggest that AI can play a critical role in enhancing clinical decision-making and improving the accuracy of TN diagnosis, ultimately aiding in better treatment planning for patients.
- Open Access
- 28 January 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Primary ( AL ) Amyloidosis Following COVID ‐19 Infection: A Case Report
Primary (AL) amyloidosis is a rare systemic disorder caused by extracellular deposition of monoclonal immunoglobulin light chains, resulting in multi‐organ dysfunction. SARS‐CoV‐2 infection may induce persistent inflammatory and immune dysregulation, potentially promoting amyloid formation, although clinical evidence is limited, making the recognition of post‐COVID‐19 amyloidosis clinically relevant and potentially novel. A 39‐year‐old Caucasian male presented with progressive weight loss (18 kg over 6 months), epigastric pain, early satiety, and hepatosplenomegaly. Ten months prior, he had recovered from COVID‐19 with mild pulmonary involvement. Initial ultrasonography and endoscopy were unremarkable except for mild gastritis. Subsequent imaging revealed hepatosplenomegaly (liver: 200 mm; spleen: 157 mm) and cholestatic liver enzyme elevation. Investigations for sclerosing cholangitis were negative. Liver biopsy with Congo red staining confirmed amyloid deposition, and bone marrow analysis revealed clonal plasma cells, establishing primary (AL) amyloidosis. Echocardiography showed left ventricular hypertrophy (LVH) due to amyloid infiltration. This case underscores a possible association between SARS‐CoV‐2 infection and primary amyloidosis. Post‐COVID inflammatory responses, elevated serum amyloid A, oxidative stress, and hypercoagulability may collectively facilitate amyloidogenic peptide formation and tissue deposition. Molecular dynamics studies further support the plausibility of SARS‐CoV‐2–induced amyloidogenesis. Primary amyloidosis may develop following COVID‐19. Clinicians should consider amyloidosis in patients with unexplained weight loss, hepatosplenomegaly, or cholestatic liver enzyme abnormalities after SARS‐CoV‐2 infection. Early biopsy and type‐specific diagnosis are essential for timely management. This case highlights the potential clinical significance of a post‐COVID‐19 association, as primary amyloidosis may develop following COVID‐19.
- 28 January 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Open AccessPrimary ( AL ) Amyloidosis Following COVID ‐19 Infection: A Case Report
Primary (AL) amyloidosis is a rare systemic disorder caused by extracellular deposition of monoclonal immunoglobulin light chains, resulting in multi‐organ dysfunction. SARS‐CoV‐2 infection may induce persistent inflammatory and immune dysregulation, potentially promoting amyloid formation, although clinical evidence is limited, making the recognition of post‐COVID‐19 amyloidosis clinically relevant and potentially novel. A 39‐year‐old Caucasian male presented with progressive weight loss (18 kg over 6 months), epigastric pain, early satiety, and hepatosplenomegaly. Ten months prior, he had recovered from COVID‐19 with mild pulmonary involvement. Initial ultrasonography and endoscopy were unremarkable except for mild gastritis. Subsequent imaging revealed hepatosplenomegaly (liver: 200 mm; spleen: 157 mm) and cholestatic liver enzyme elevation. Investigations for sclerosing cholangitis were negative. Liver biopsy with Congo red staining confirmed amyloid deposition, and bone marrow analysis revealed clonal plasma cells, establishing primary (AL) amyloidosis. Echocardiography showed left ventricular hypertrophy (LVH) due to amyloid infiltration. This case underscores a possible association between SARS‐CoV‐2 infection and primary amyloidosis. Post‐COVID inflammatory responses, elevated serum amyloid A, oxidative stress, and hypercoagulability may collectively facilitate amyloidogenic peptide formation and tissue deposition. Molecular dynamics studies further support the plausibility of SARS‐CoV‐2–induced amyloidogenesis. Primary amyloidosis may develop following COVID‐19. Clinicians should consider amyloidosis in patients with unexplained weight loss, hepatosplenomegaly, or cholestatic liver enzyme abnormalities after SARS‐CoV‐2 infection. Early biopsy and type‐specific diagnosis are essential for timely management. This case highlights the potential clinical significance of a post‐COVID‐19 association, as primary amyloidosis may develop following COVID‐19.
- Open Access
- 17 December 2025
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Diagnostic accuracy of CT-based radiomics models in differentiating lung cancer from tuberculosis in pulmonary lesions: a systematic review and meta-analysis
Distinguishing lung cancer (LC) from pulmonary tuberculosis (TB) on CT is difficult. We synthesized evidence on radiomics, clinical, and combined models fo
- 17 December 2025
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Open AccessDiagnostic accuracy of CT-based radiomics models in differentiating lung cancer from tuberculosis in pulmonary lesions: a systematic review and meta-analysis
Distinguishing lung cancer (LC) from pulmonary tuberculosis (TB) on CT is difficult. We synthesized evidence on radiomics, clinical, and combined models fo
- Open Access
- 1 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (10)
Heterotopic Pancreas in the Gallbladder: An Incidental Finding Following Laparoscopic Cholecystectomy in a Patient With Cholelithiasis
Heterotopic pancreas (HP)—defined as ectopic pancreatic tissue lacking vascular or ductal connections to the main organ—represents an exceedingly rare anatomical variant in the gallbladder. This developmental anomaly warrants careful clinical attention due to its potential surgical implications. We report a case of a 38‐year‐old female who presented to the emergency department with progressive abdominal pain, nausea, and vomiting. Ultrasonographic evaluation revealed a solitary 15‐mm gallstone without evidence of gallbladder wall inflammation. Following laparoscopic cholecystectomy, histological examination of the 7.5 cm × 3 cm specimen demonstrated acute‐on‐chronic cholecystitis with localized cholesterolosis. Microscopic evaluation revealed heterotopic pancreatic tissue beneath the gallbladder fundus serosa. The tissue displayed complete pancreatic architecture—including acini, ducts, and islets of Langerhans—without evidence of malignancy or dysplasia. The patient experienced an uncomplicated postoperative course, with complete symptom resolution during follow‐up. This case emphasizes the importance of thorough histopathological examination in identifying rare anatomical variants and contributes to the limited literature on gallbladder HP. While typically asymptomatic, recognition of HP remains crucial for appropriate surgical planning and patient management.
- 1 October 2025
- Published by Wiley in Clinical Case Reports
- Vol. 13 (10)
Open AccessHeterotopic Pancreas in the Gallbladder: An Incidental Finding Following Laparoscopic Cholecystectomy in a Patient With Cholelithiasis
Heterotopic pancreas (HP)—defined as ectopic pancreatic tissue lacking vascular or ductal connections to the main organ—represents an exceedingly rare anatomical variant in the gallbladder. This developmental anomaly warrants careful clinical attention due to its potential surgical implications. We report a case of a 38‐year‐old female who presented to the emergency department with progressive abdominal pain, nausea, and vomiting. Ultrasonographic evaluation revealed a solitary 15‐mm gallstone without evidence of gallbladder wall inflammation. Following laparoscopic cholecystectomy, histological examination of the 7.5 cm × 3 cm specimen demonstrated acute‐on‐chronic cholecystitis with localized cholesterolosis. Microscopic evaluation revealed heterotopic pancreatic tissue beneath the gallbladder fundus serosa. The tissue displayed complete pancreatic architecture—including acini, ducts, and islets of Langerhans—without evidence of malignancy or dysplasia. The patient experienced an uncomplicated postoperative course, with complete symptom resolution during follow‐up. This case emphasizes the importance of thorough histopathological examination in identifying rare anatomical variants and contributes to the limited literature on gallbladder HP. While typically asymptomatic, recognition of HP remains crucial for appropriate surgical planning and patient management.
- Open Access
- 26 August 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-12
The significance of S100β and neuron-specific enolase (NSE) in postoperative cognitive dysfunction following cardiac surgery: a systematic review and meta-analysis
Postoperative cognitive dysfunction (POCD) significantly affects recovery, hospitalization duration, and quality of life following cardiac surgery. Identifying reliable biomarkers for predicting POCD could improve patient outcomes and perioperative care. Among these, S100 calcium-binding protein beta (S100β) and neuron-specific enolase (NSE) have emerged as promising indicators of cerebral injury and neurocognitive dysfunction. This systematic review and meta-analysis aimed to assess within-subject perioperative changes in S100β and NSE levels among patients who developed POCD after cardiac surgery, to evaluate whether these biomarkers consistently rise in association with POCD. Following PRISMA guidelines, we searched PubMed, Scopus, and Web of Science up to October 2024. Studies included peer-reviewed articles evaluating S100β and NSE levels in relation to POCD in cardiac surgery patients. Two reviewers independently extracted data and assessed the quality using the ROBINS-I tool. Meta-analyses were conducted using a random-effects model. Thirty studies were included. Among patients who developed POCD, both S100β and NSE levels were significantly elevated postoperatively compared to preoperative baselines. The pooled standardized mean difference (SMD) was 1.52 (95% CI 0.57–2.48; I2 = 93.1%) for S100β and 1.19 (95% CI 0.42–1.96; I2 = 88.7%) for NSE, indicating large effect sizes. Sensitivity analyses confirmed the robustness of these findings despite substantial heterogeneity. Among patients who developed POCD, S100β and NSE levels significantly increased from preoperative to postoperative measurements, indicating a potential association with cerebral injury. However, as non-POCD patients were not analyzed for the same biomarker changes, causality or specificity to POCD cannot be confirmed and future research should be directed toward between group changes.
- 26 August 2025
- Published by Springer Nature in European Journal of Medical Research
- Vol. 30 (1) , 1-12
Open AccessThe significance of S100β and neuron-specific enolase (NSE) in postoperative cognitive dysfunction following cardiac surgery: a systematic review and meta-analysis
Postoperative cognitive dysfunction (POCD) significantly affects recovery, hospitalization duration, and quality of life following cardiac surgery. Identifying reliable biomarkers for predicting POCD could improve patient outcomes and perioperative care. Among these, S100 calcium-binding protein beta (S100β) and neuron-specific enolase (NSE) have emerged as promising indicators of cerebral injury and neurocognitive dysfunction. This systematic review and meta-analysis aimed to assess within-subject perioperative changes in S100β and NSE levels among patients who developed POCD after cardiac surgery, to evaluate whether these biomarkers consistently rise in association with POCD. Following PRISMA guidelines, we searched PubMed, Scopus, and Web of Science up to October 2024. Studies included peer-reviewed articles evaluating S100β and NSE levels in relation to POCD in cardiac surgery patients. Two reviewers independently extracted data and assessed the quality using the ROBINS-I tool. Meta-analyses were conducted using a random-effects model. Thirty studies were included. Among patients who developed POCD, both S100β and NSE levels were significantly elevated postoperatively compared to preoperative baselines. The pooled standardized mean difference (SMD) was 1.52 (95% CI 0.57–2.48; I2 = 93.1%) for S100β and 1.19 (95% CI 0.42–1.96; I2 = 88.7%) for NSE, indicating large effect sizes. Sensitivity analyses confirmed the robustness of these findings despite substantial heterogeneity. Among patients who developed POCD, S100β and NSE levels significantly increased from preoperative to postoperative measurements, indicating a potential association with cerebral injury. However, as non-POCD patients were not analyzed for the same biomarker changes, causality or specificity to POCD cannot be confirmed and future research should be directed toward between group changes.
- Open Access
- 12 June 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-11
miR-146a-5p suppresses migration and downregulates vimentin and MMP-9 expression in gastric cancer cells
Gastric cancer (GC) is a significant global health issue, characterized by poor prognosis due to its metastatic nature. This study investigates the role of microRNA-146a-5p (miR-146a-5p) in regulating migration and invasion of KATO III GC cells by targeting vimentin and matrix metalloproteinase-9 (MMP-9), critical mediators of epithelial–mesenchymal transition (EMT). miR-146a-5p expression was analyzed in GC cell lines, and functional assays were performed after transfection with a miR-146a-5p mimic. Results showed that miR-146a-5p expression was significantly reduced in GC cells, particularly in KATO III. Transfection with the mimic reduced cell viability, increased apoptosis, and inhibited migration, as shown by wound-healing assays. Additionally, miR-146a-5p downregulated vimentin and MMP-9 mRNA expression. These findings suggest that miR-146a-5p may influence metastatic behavior in GC cells through regulation of EMT-related genes. However, further studies, including protein-level validation and direct target confirmation, are needed. These results provide a basis for future investigation into the potential therapeutic role of miR-146a-5p in GC.
- 12 June 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-11
Open AccessmiR-146a-5p suppresses migration and downregulates vimentin and MMP-9 expression in gastric cancer cells
Gastric cancer (GC) is a significant global health issue, characterized by poor prognosis due to its metastatic nature. This study investigates the role of microRNA-146a-5p (miR-146a-5p) in regulating migration and invasion of KATO III GC cells by targeting vimentin and matrix metalloproteinase-9 (MMP-9), critical mediators of epithelial–mesenchymal transition (EMT). miR-146a-5p expression was analyzed in GC cell lines, and functional assays were performed after transfection with a miR-146a-5p mimic. Results showed that miR-146a-5p expression was significantly reduced in GC cells, particularly in KATO III. Transfection with the mimic reduced cell viability, increased apoptosis, and inhibited migration, as shown by wound-healing assays. Additionally, miR-146a-5p downregulated vimentin and MMP-9 mRNA expression. These findings suggest that miR-146a-5p may influence metastatic behavior in GC cells through regulation of EMT-related genes. However, further studies, including protein-level validation and direct target confirmation, are needed. These results provide a basis for future investigation into the potential therapeutic role of miR-146a-5p in GC.
- 20 May 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (6) , 103238
A Comprehensive Review of Behcet’s Disease Damage Assessment Tools
- 20 May 2025
- Published by Elsevier in Archives of Medical Research
- Vol. 56 (6) , 103238
A Comprehensive Review of Behcet’s Disease Damage Assessment Tools
- 1 May 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (7) , 957-971
The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials
Treatment of hepatic diseases presents a significant challenge due to their diverse nature. Ginsenosides, bioactive compounds derived from the root of Panax ginseng and widely used in traditional Chinese medicine, offer multifaceted protection to various organs in the body. Their versatile effects, including antioxidant, anti-inflammatory, anti-apoptotic and more, make them a promising approach for addressing hepatic disorders. This review explores the intricate molecular mechanisms and properties of ginsenosides in the prevention and treatment of liver ailments, from mild conditions to severe damage and liver fibrosis. Given the increasing prevalence of hepatic disorders, this article sheds light on the significant pharmaceutical potential of ginsenosides in the realm of hepatic disease management.
- 1 May 2025
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Biotechnology
- Vol. 26 (7) , 957-971
The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials
Treatment of hepatic diseases presents a significant challenge due to their diverse nature. Ginsenosides, bioactive compounds derived from the root of Panax ginseng and widely used in traditional Chinese medicine, offer multifaceted protection to various organs in the body. Their versatile effects, including antioxidant, anti-inflammatory, anti-apoptotic and more, make them a promising approach for addressing hepatic disorders. This review explores the intricate molecular mechanisms and properties of ginsenosides in the prevention and treatment of liver ailments, from mild conditions to severe damage and liver fibrosis. Given the increasing prevalence of hepatic disorders, this article sheds light on the significant pharmaceutical potential of ginsenosides in the realm of hepatic disease management.
- Open Access
- 18 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1
Author Correction: Serum vitamin D levels and their correlation with pro-inflammatory prostaglandins in Acute myeloid leukemia: a cross-sectional analysis
- 18 March 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1
Open AccessAuthor Correction: Serum vitamin D levels and their correlation with pro-inflammatory prostaglandins in Acute myeloid leukemia: a cross-sectional analysis
- 24 January 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-15
Prediction of facial nerve outcomes after surgery for vestibular schwannoma using machine learning-based models: a systematic review and meta-analysis
Postoperative facial nerve (FN) dysfunction is associated with a significant impact on the quality of life of patients and can result in psychological stress and disorders such as depression and social isolation. Preoperative prediction of FN outcomes can play a critical role in vestibular schwannomas (VSs) patient care. Several studies have developed machine learning (ML)-based models in predicting FN outcomes following resection of VS. This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy of ML-based models in predicting FN outcomes following resection in the setting of VS. On December 12, 2024, the four electronic databases, Pubmed, Embase, Scopus, and Web of Science, were systematically searched. Studies that evaluated the performance outcomes of the ML-based predictive models were included. The pooled sensitivity, specificity, area under the curve (AUC), and diagnostic odds ratio (DOR) were calculated through the R program. Five studies with 807 individuals with VS, encompassing 35 models, were included. The meta-analysis showed a pooled sensitivity of 82% (95%CI: 76-87%), specificity of 79% (95%CI: 74-84%), and DOR of 12.94 (95%CI: 8.65–19.34) with an AUC of 0.841. The meta-analysis of the best performance model demonstrated a pooled sensitivity of 91% (95%CI: 80-96%), specificity of 87% (95%CI: 82-91%), and DOR of 46.84 (95%CI: 19.8-110.8). Additionally, the analysis demonstrated an AUC of 0.92, a sensitivity of 0.884, and a false positive rate of 0.136 for the best performance models. ML-based models possess promising diagnostic accuracy in predicting FN outcomes following resection.
- 24 January 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-15
Prediction of facial nerve outcomes after surgery for vestibular schwannoma using machine learning-based models: a systematic review and meta-analysis
Postoperative facial nerve (FN) dysfunction is associated with a significant impact on the quality of life of patients and can result in psychological stress and disorders such as depression and social isolation. Preoperative prediction of FN outcomes can play a critical role in vestibular schwannomas (VSs) patient care. Several studies have developed machine learning (ML)-based models in predicting FN outcomes following resection of VS. This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy of ML-based models in predicting FN outcomes following resection in the setting of VS. On December 12, 2024, the four electronic databases, Pubmed, Embase, Scopus, and Web of Science, were systematically searched. Studies that evaluated the performance outcomes of the ML-based predictive models were included. The pooled sensitivity, specificity, area under the curve (AUC), and diagnostic odds ratio (DOR) were calculated through the R program. Five studies with 807 individuals with VS, encompassing 35 models, were included. The meta-analysis showed a pooled sensitivity of 82% (95%CI: 76-87%), specificity of 79% (95%CI: 74-84%), and DOR of 12.94 (95%CI: 8.65–19.34) with an AUC of 0.841. The meta-analysis of the best performance model demonstrated a pooled sensitivity of 91% (95%CI: 80-96%), specificity of 87% (95%CI: 82-91%), and DOR of 46.84 (95%CI: 19.8-110.8). Additionally, the analysis demonstrated an AUC of 0.92, a sensitivity of 0.884, and a false positive rate of 0.136 for the best performance models. ML-based models possess promising diagnostic accuracy in predicting FN outcomes following resection.